Company News: Pfizer invests in Boston-area hospitals, Centron takes on OraPharma

Share this article:

Making good on its global initiative to bolster science and academia, New York-based pharma giant Pfizer has announced plans to invest $100 million with Boston's Longwood Medical Area. The investment will be made over the next five years and includes the establishment of a resource space – to be called the Center for Therapeutic Innovation – which will create about 50 new jobs. The aim of the company's partnership with Boston-area hospitals and med schools is to shorten the gaps that occur in the R&D stages of drug development.

Medical communications agency Centron has announced an account win with oral health company OraPharma. The agency will oversee medical communications responsibilities for Arestin, a localized antibiotic used in periodontics. “We're very excited to be chosen to guide development and execution of medical communications for Arestin,” said Marcia McLaughlin, President & CEO of Centron, in a release. “Our staff is ready to join the OraPharma team and deliver the strategic excellence we strive for every day.”

Share this article:

Email Newsletters

More in Business Briefs

Miss Idaho shows off diabetes pump

NPR reports that the move has made Sierra Sandison a type 1 diabetes hero and that users have given the Facebook photo over 4,000 "likes."

Roche is hungry, not starving for M&A

CEO Severin Schwan tells Reuters that the Swiss firm will be looking for small acquisitions and partnerships.

AbbVie nabs Shire for $54B

AbbVie, in the latest example of a US drugmaker seeking to lower its tax rate, said today that it's buying Dublin-based Shire for $54 billion.